HemaSphere (Jun 2022)

PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA

  • J.-F. Bai,
  • J. T. Li,
  • R. Feng,
  • L. Qian,
  • J. Yin,
  • H. Liu

DOI
https://doi.org/10.1097/01.HS9.0000851220.50282.7c
Journal volume & issue
Vol. 6
pp. 1968 – 1969

Abstract

Read online

No abstracts available.